Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Collins Oghor"'
Autor:
Madhukar Pai, Harkesh Dabas, Sarang Deo, Manisha Sabharwal, Arnab Pal, Sachin Salim, Lakshmi Nair, Kaartikeya Chauhan, Prateek Maheshwari, Aparna Parulkar, Ritu Singh, Manasi Chitalia, Rigveda Kadam, Manjot Kaur, Collins Oghor, Nirros Ponnudurai, Sameer Kumta, Peter Small, Puneet Dewan
Publikováno v:
BMJ Global Health, Vol 4, Iss 6 (2019)
A majority of patients with tuberculosis (TB) in India are diagnosed and treated in the private sector. Yet, most private providers do not use most recent WHO-endorsed microbiological tests such as liquid cultures, line probe assays and Xpert MTB/RIF
Externí odkaz:
https://doaj.org/article/7f5c699c38e1476c9375de0c2afda0ea
Publikováno v:
The Lancet Global Health, Vol 4, Iss 2, Pp e94-e95 (2016)
Externí odkaz:
https://doaj.org/article/ad5fd0fa0c4e4adaa71472ab223a731f
Autor:
Danielle Cazabon, Christian Vlček, Mary Helmer-Smith, Margherita Cinà, Aimee R. Castro, Collins Oghor
Publikováno v:
Journal of Health Specialties, Vol 5, Iss 1, Pp 2-7 (2017)
Human papillomavirus (HPV), a sexually transmitted DNA virus that can lead to cervical cancer, is the most common cancer among women in developing regions. More than 270,000 women die per year from cervical cancer globally, and 85% of those deaths oc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae3c7d3c8c759e142214c9d16dfa836
http://www.thejhs.org/article.asp?issn=2468-6360
http://www.thejhs.org/article.asp?issn=2468-6360
Autor:
Aparna Parulkar, Manasi Chitalia, Ritu Singh, Kaartikeya Chauhan, Harkesh Dabas, Lakshmi Nair, Sarang Deo, Arnab Pal, Madhukar Pai, Nirros Ponnudurai, R.M. Kadam, Prateek Maheshwari, Puneet Dewan, Manisha Sabharwal, Manjot Kaur, Peter M. Small, Sameer Kumta, Sachin Salim, Collins Oghor
Publikováno v:
BMJ Global Health, Vol 4, Iss 6 (2019)
BMJ Global Health
BMJ Global Health
A majority of patients with tuberculosis (TB) in India are diagnosed and treated in the private sector. Yet, most private providers do not use most recent WHO-endorsed microbiological tests such as liquid cultures, line probe assays and Xpert MTB/RIF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b42ead9535498b40930fe4557e238d8b
https://doi.org/10.1136/bmjgh-2019-001539
https://doi.org/10.1136/bmjgh-2019-001539
Publikováno v:
The Lancet Global Health, Vol 4, Iss 2, Pp e94-e95 (2016)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dce189c4fc9818b89bd28560fa56384
Autor:
Sandra V. Kik, Madhukar Pai, Danielle Cazabon, Zhi Zhen Qin, Collins Oghor, Anita Suresh, Claudia M. Denkinger
Publikováno v:
The European Respiratory Journal
By the end of 2016, approximately 23 million Xpert MTB/RIF® (Xpert; Cepheid, Sunnyvale, CA, USA) cartridges for tuberculosis (TB) diagnosis had been procured by the public sector in 130 countries at concessional pricing [1], but smear microscopy con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff83453195246b91f090f760abc34ae
https://doi.org/10.1183/13993003.00918-2017
https://doi.org/10.1183/13993003.00918-2017